Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $44.00 (+37.2%) * Over Last 12-Mos
Rating Score: 3.6 / 10   Percentile Rank: 37%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/7/2016 Avondale Partners New Coverage Market Outperform
(N/A)
50.00
(N/A)
42.27 32.07 -24.13% Details
1/7/2016 Deutsche Bank New Coverage Buy
(N/A)
52.00
(N/A)
42.27 32.07 -24.13% Details
Like MYGN Ratings? Also take a look at TSRO, NDAQ, ABBV, NVTA

MYGN Ratings News